Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
Company

China's Fosun Pharma to acquire 74 pct stake in Gland Pharma

September 19, 2017


Abstract : China's Fosun Pharmaceutical (Group) plans to acquire a 74 percent stake in Indian injectables manufacturer Gland Pharma for nearly 1.1 billion U.S. dollars.

复星医药

SHANGHAI, Sept. 18 (Xinhua) -- China's Fosun Pharmaceutical (Group) plans to acquire a 74 percent stake in Indian injectables manufacturer Gland Pharma for nearly 1.1 billion U.S. dollars.

Last year, Fosun offered to buy 86 percent of the firm, a deal worth up to 1.26 billion U.S. dollars.

The current offer includes a payment capped at 25 million dollars for Gland's sales of Enoxaparin in the United States, according to a statement from Fosun on Sunday.

Founded in 1978, Hyderabad-based Gland Pharma is the first company in India to be approved by the U.S. Food and Drug Administration for injectable liquid medicines. The U.S. and European markets account for the majority of its revenue.

Fosun Pharma's chairman Chen Qiyu said the deal would strengthen the Chinese pharmaceutical firm's global presence.

Scan the QR code and push it to your mobile phone

Keyword: Fosun_Group Fosun-Pharma Gland-Pharma

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial